Accenture: Clinical and Regulatory Information Management Services To Be Expanded

By Rob Starr, Content Manager, Big4.com

Accenture (NYSE: ACN) has acquired Octagon Research Solutions, Inc., a provider of clinical and regulatory information management solutions and software for the pharmaceutical industry. Terms of the transaction were not disclosed.  Octagon’s 380-member staff has deep experience in clinical data services and regulatory submissions, with 400 original applications completed, and the company is the fifth largest user of the U.S. Food and Drug Administration’s (FDA) electronic submission gateway.

The acquisition will enhance Accenture’s ability to help its pharmaceutical clients achieve more efficient global regulatory submissions that will enable them to get medicines to market more quickly, safely and at a lower cost.   Accenture’s capabilities will be expanded to include comprehensive clinical and regulatory services – from clinical data collection to regulatory submissions management.  Accenture also will extend its business process outsourcing (BPO) services portfolio targeting the pharmaceutical industry.

David Boath, North American managing director for Accenture’s Life Sciences industry group commented saying:

“Our clients have an urgent need to focus resources on the scientific breakthroughs and also to improve the efficiency of their clinical and regulatory operations. Octagon’s capabilities and experience will enable Accenture to provide comprehensive services spanning regulatory operations, submissions management, clinical data conversion and clinical data management.  The acquisition will enable Accenture to offer what we view as the industry’s first comprehensive regulatory services solution with a global footprint.”